Repurposing drugs: the opportunity and the challenges
Sign up for our seminar on intellectual property, regulation, commercial positioning and patient involvement.
LifeArc’s Head of Ventures, Clare Terlouw speaks with @FT Global Pharma Correspondent @hannahkuchler discussing RQ… https://t.co/fqrxEXr3Xf
LifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
February 15, 2021: Medical research charity, LifeArc, announces today that it is providing £5 million funding to…
Celebrating UN International Day of Women and Girls in Science 2021
At a time when the world is looking to science for the answers, LifeArc marks the UN’s…
LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of…
LifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging…
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge…
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…